This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Barta SK , Joshi J , Mounier N , Xue X , Wang D , Ribera JM , Navarro JT , Hoffmann C , Dunleavy K , Little RF , Wilson WH , Spina M , Galicier L , Noy A , Sparano JA
Central nervous system involvement in AIDS-related lymphomas
Br J Haematol. 2016 Apr 7;173(6) :857-66
PMID: 27062389 PMCID: PMC4900917 URL: http://www.ncbi.nlm.nih.gov/pubmed/27062389
AbstractCentral nervous system (CNS) involvement is reportedly more common in acquired immunodeficiency syndrome (AIDS)-related lymphomas (ARL). We describe factors and outcomes associated with CNS involvement at baseline (CNSB ) and relapse (CNSR ) in 886 patients with newly diagnosed ARL. Of 886 patients, 800 received either intrathecal (IT) therapy for CNSB or IT prophylaxis. CNSB was found in 13%. CNSB was not associated with reduced overall survival (OS). There was no difference in the prevalence of CNSB between the pre-combination antiretroviral therapy (cART) and cART eras. 5.3% of patients experienced CNSR at a median of 4.2 months after diagnosis (12% if CNSB ; 4% if not). Median OS after CNSR was 1.6 months. On multivariate analysis, only CNSB [hazard ratio (HR) 3.68, P = 0.005] and complete response to initial therapy (HR 0.14, P < 0.0001) were significantly associated with CNSR . When restricted to patients without CNSB , IT CNS prophylaxis with 3 vs. 1 agent did not significantly impact the risk of CNSR . Despite IT CNS prophylaxis, 5% of patients experienced CNSR . Our data confirms that CNSR in ARL occurs early and has a poor outcome. Complete response to initial therapy was associated with a reduced frequency of CNSR . Although CNSB conferred an increased risk for CNSR , it did not impact OS.
Notes1365-2141 Barta, Stefan K Joshi, Jitesh Mounier, Nicolas Xue, Xiaonan Wang, Dan Ribera, Josep-Maria Navarro, Jose-Tomas Hoffmann, Christian Dunleavy, Kieron Little, Richard F Wilson, Wyndham H Spina, Michele Galicier, Lionel Noy, Ariela Sparano, Joseph A K12 CA132783/CA/NCI NIH HHS/United States KL2 RR025749/RR/NCRR NIH HHS/United States TL1 RR025748/RR/NCRR NIH HHS/United States U01 CA121947/CA/NCI NIH HHS/United States UL1 RR025750/RR/NCRR NIH HHS/United States Journal article Br J Haematol. 2016 Apr 7. doi: 10.1111/bjh.13998.